Bridgepoint / Bridgepoint to sell Rovensa in €1 billion transaction

Partners Group, the global private markets investment manager, has on behalf of its clients agreed to acquire a major equity stake in Rovensa (“Rovensa” or “the Company”), a leading provider of specialty crop nutrition, biocontrol and protection products, from Bridgepoint, a major international private equity group. The transaction values the Company at an enterprise value of around EUR 1 billion.

Rovensa’s portfolio of agricultural solutions and
technologies helps farmers to enhance crop yields and provide food
security. Founded in 1926 and headquartered in Portugal, the
Company has three divisions: BioNutrition, which provides
agricultural crops with nutrients for growth and healthy
development; Crop Protection, which eliminates or prevents
biological threats in crops; and BioControl, which offers products
based on biological inputs, such as plant extracts and
micro-organisms. Rovensa specializes in formulating sustainable
products which reduce the environmental impact of
agriculture, combat its contribution to climate
change and support the cultivation of healthy food.  Its
products are sold in more than 70 countries and generate an annual
revenue of approximately EUR 360 million. 

Following the investment, Partners Group will work
closely with Rovensa’s management team, led by Chief Executive
Officer Eric van Innis, on several key strategic initiatives,
including the accelerated development of the company’s leading
biological solutions portfolio, the continued internationalization
of the company, and select further acquisitions to continue to
build its capabilities. In addition, Partners Group plans to
continue to support the company’s research and development culture,
focusing on high-growth market niches. 

More:  Bridgepoint / BDC to partner with Matrix SCM

Eric Van Innis, Chief Executive Officer, Rovensa,
says: “We have benefitted greatly from Bridgepoint’s ownership
since 2017 and our recent growth trajectory reflects this. However,
with a growing global population, ambitious environmental
targets, and health concerns, the agricultural sector remains
essential and we believe its strategic importance ensures there are
further exciting growth opportunities ahead. We are convinced that
Partners Group, with its global presence and focus on
entrepreneurial ownership, is the right partner with which to
continue building Rovensa’s platform and seize those opportunities.
We look forward to working hand-in-hand with Partners Group’s
team in this next phase of growth and to corresponding to
their trust in our project.”

Andrew Deakin, Managing Director, Private Equity
Directs Europe, Partners Group, states: “Rovensa represents a great
opportunity to support a resilient business in a market
characterized by steady long-term growth. The Company is ideally
positioned to capitalize on the growing trend towards sustainable
agricultural products, which will be a core element of the strategy
we will continue to pursue. We were attracted to the Company’s
reputation, talented management team and high-quality product
portfolio and see compelling potential for accelerated growth. We
are very excited about this meaningful investment in Iberia and are
looking forward to supporting Rovensa’s continued growth
journey.”

Hector Perez, partner responsible for Bridgepoint’s
investment activities in the Iberian region, says: “We are
extremely pleased with the progress made by Rovensa since our
acquisition in 2017. Today it leads the field globally in
BioSolutions and its products have become a prominent component in
sustainable agriculture. The business has made a significant leap
forward both through continued organic development, fueled by its
product innovation capabilities, and through the execution of six
strategic add-on acquisitions. We have enjoyed an extremely
productive relationship with a talented management team, led
by Eric van Innis and Nuno Loureiro, and are
confident of the continued growth of the business in its
sector.”

More:  Bridgepoint / BDC exits KGH

Advisers to Bridgepoint were: HSBC, J.P.
Morgan, Uría Menéndez, McKinsey and PwC.


More from: | Category: Private Equity Company News